Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
769 Interim clinical and translational data from NTC-001, a phase I study to evaluate the non-engineered neoantigen-specific T cell product BNT221 in patients with advanced or metastatic melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.